Reply to Volkman et al. Comment on "Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434"

被引：0
|
作者：
Kohli, Michele [1 ]
Joshi, Keya [2 ]
Beck, Ekkehard [2 ]
Hagiwara, Yuriko [3 ]
Van de Velde, Nicolas [2 ]
Igarashi, Ataru [4 ]
机构：
[1] Quadrant Hlth Econ Inc, 92 Cottonwood Crescent, Cambridge, ON N1T 2J1, Canada
[2] Moderna Inc, 325 Binney St, Cambridge, MA 02142 USA
[3] Moderna Inc, 4-1-1 Toranomon,Kamiyacho,Minato Ku, Tokyo 1056923, Japan
[4] Univ Tokyo, Grad Sch Pharmaceut Sci, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
来源：
VACCINES | 2024年 / 12卷 / 10期
关键词：
coronavirus; SARS-CoV-2; Japan; COVID-19; vaccination; cost-effectiveness;
D O I：
10.3390/vaccines12101175
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Zupanic et al.
    Galassi, Giuliana
    Marchioni, Alessandro
    ACTA NEUROLOGICA BELGICA, 2022, 122 (02) : 559 - 560
  • [42] Comment on Cheng et al.'s "Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders"
    Chu, Wei -Min
    Ho, Hsin-En
    Wei, James Cheng-Chung
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 115 : 333 - 334
  • [43] Comment on Williamson et al. (OpenSAFELY): The Table 2 Fallacy in a Study of COVID-19 Mortality Risk Factors
    Westreich, Daniel
    Edwards, Jessie K.
    van Smeden, Maarten
    EPIDEMIOLOGY, 2021, 32 (01) : E1 - E2
  • [44] Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.
    Giuliana Galassi
    Alessandro Marchioni
    Acta Neurologica Belgica, 2022, 122 : 559 - 560
  • [45] Reply to Boning et al. Comment on "Ceruti et al. Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients. J. Clin. Med. 2022, 11, 788"
    Ceruti, Samuele
    Minotti, Bruno
    Glotta, Andrea
    Biggiogero, Maira
    Bona, Giovanni
    Marzano, Martino
    Greco, Pietro
    Spagnoletti, Marco
    Garzoni, Christian
    Bendjelid, Karim
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [46] Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure"
    Fedson, David S.
    Opal, Steven M.
    Rordam, Ole Martin
    MBIO, 2020, 11 (03):
  • [47] Reply to Basseal et al.'s "Key lessons from the COVID-19 public health response in Australia"
    Silva, Diego S.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 30
  • [48] Ambra et al. Could Selenium Supplementation Prevent COVID-19? A Comprehensive Review of Available Studies Reply
    Ambra, Roberto
    Melloni, Sahara
    Venneria, Eugenia
    MOLECULES, 2024, 29 (11):
  • [49] Reply to: "Concerns Raised by Publication of Antonini et al., 'Outcome of Parkinson Disease Patients Affected by Covid-19'"
    Antonini, Angelo
    Leta, Valentina
    Teo, James
    Ray Chaudhuri, K.
    MOVEMENT DISORDERS, 2020, 35 (08) : 1298 - 1298
  • [50] Evidence for (mis-)understanding or obfuscation in the COVID-19 and digit ratio relationship? A reply to Jones et al.
    Manning, John T.
    Fink, Bernhard
    EARLY HUMAN DEVELOPMENT, 2020, 148
12345